Abstract
The COVID-19 pandemic presented enormous data challenges in the United States. Policy makers, epidemiological modelers, and health researchers all require up-to-date data on the pandemic and relevant public behavior, ideally at fine spatial and temporal resolution. The COVIDcast API is our attempt to fill this need: operational since April 2020, it provides open access to both traditional public health surveillance signals (cases, deaths, and hospitalizations) and many auxiliary indicators of COVID-19 activity, such as signals extracted from de-identified medical claims data, massive online surveys, cell phone mobility data, and internet search trends. These are available at a fine geographic resolution (mostly at the county level) and are updated daily. The COVIDcast API also tracks all revisions to historical data, allowing modelers to account for the frequent revisions and backfill that are common for many public health data sources. All of the data is available in a common format through the API and accompanying R and Python software packages. This paper describes the data sources and signals, and provides examples demonstrating that the auxiliary signals in the COVIDcast API present information relevant to tracking COVID activity, augmenting traditional public health reporting and empowering research and decision-making.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This material is based on work supported by gifts from Facebook, Google.org, the McCune Foundation, and Optum; Centers for Disease Control and Prevention (CDC) grant U01IP001121; National Science Foundation Graduate Research Fellowship Program (NSF GRFP) award DGE1745016; and the Center for Machine Learning and Health (CMLH) at Carnegie Mellon.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Carnegie Mellon University Institutional Review Board reviewed the surveys as STUDY2020_00000162, and determined that the use of deidentified medical claims and test results was not human subjects research. All other data is from publicly available sources.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Expanded supplementary information; clarified limitations; new analyses in Results section.
Data Availability
All data used in the article is freely available in the public COVIDcast API. Code used to produce figures and results is available at https://doi.org/10.5281/zenodo.5639567
https://cmu-delphi.github.io/delphi-epidata/api/covidcast.html
